World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
134
Citations
94983
World Ranking
2101
National Ranking
1188

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Everett E. Vokes is affiliated with the University of Chicago in the United States and has contributed extensively to the field of Medicine, particularly focusing on Oncology, Pulmonary and Respiratory Medicine, and Otorhinolaryngology. Their research portfolio includes 337 publications in Medicine, with 120 in Oncology, 98 in Pulmonary and Respiratory Medicine, 44 in Otorhinolaryngology, 27 in Surgery, and 24 in Molecular Biology.

The main topics of their work cover a range of cancer-related subjects, including:

  • Lung Cancer Treatments and Mutations
  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging

Frequent publication venues include:

  • Journal of Clinical Oncology (28 publications)
  • International Journal of Radiation Oncology*Biology*Physics (19 publications)
  • Journal of Thoracic Oncology (16 publications)
  • UNC Libraries (10 publications)
  • Clinical Cancer Research (7 publications)

Among recent significant papers associated with their research interests are:

  • "Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer" (2023), New England Journal of Medicine
  • "Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer" (2021), Journal of Clinical Oncology
  • "Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)" (2021), Journal of Clinical Oncology
  • "Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives" (2020), The Oncologist
  • "A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study" (2021), Journal of Thoracic Oncology

Their research collaborations include frequent coauthors such as:

  • Aditya Juloori (47 joint publications)
  • Ari J. Rosenberg (45 joint publications)
  • Alexander T. Pearson (45 joint publications)
  • Nishant Agrawal (43 joint publications)
  • Elizabeth A. Blair (37 joint publications)

Everett E. Vokes has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

    H. Borghaei;L. Paz-Ares;L. Horn;D. R. Spigel

  • Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer

    Julie Brahmer;Karen L Reckamp;Paul Baas;Lucio Crinò

  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Head and neck cancer.

    Everett E. Vokes;Ralph R. Weichselbaum;Scott M. Lippman;Waun Ki Hong

  • Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

    Frank V. Fossella;Russell DeVore;Ronald N. Kerr;Jeffrey Crawford

  • Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

    Gary M. Strauss;James E. Herndon;Michael A. Maddaus;David W. Johnstone

  • Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

    Denis Soulieres;Neil N. Senzer;Everett E. Vokes;Manuel Hidalgo

  • Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

    Federico Innocenti;Samir D. Undevia;Lalitha Iyer;Pei Xian Chen

  • Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

    Leora Horn;David R. Spigel;Everett E. Vokes;Esther Holgado

  • UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

    L Iyer;S Das;L Janisch;M Wen

  • Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Ezra E. W. Cohen;Fred Rosen;Walter M. Stadler;Wendy Recant

  • The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity

    Marcy A. List;Linda L. D'Antonio;David F. Cella;Amy Siston

  • Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

    Ezra E.W. Cohen;Lee S. Rosen;Everett E. Vokes;Merrill S. Kies

  • Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

    Al B. Benson;Jaffer A. Ajani;Robert B. Catalano;Constance Engelking

  • Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

    Tanguy Y Seiwert;Zhixiang Zuo;Michaela K Keck;Arun Khattri

  • Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

    J. Nemunaitis;F. Khuri;I. Ganly;J. Arseneau

  • Predictors of Competing Mortality in Advanced Head and Neck Cancer

    Loren K. Mell;James J. Dignam;Joseph K. Salama;Ezra E.W. Cohen

  • Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea

    Elora Gupta;Timothy M. Lestingi;Rosemarie Mick;Jacqueline Ramirez

  • Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

    Everett E. Vokes;James E. Herndon;Michael J. Kelley;M. Giulia Cicchetti

Frequent Co-Authors

Ralph R. Weichselbaum
Ralph R. Weichselbaum University of Chicago
Ezra E.W. Cohen
Ezra E.W. Cohen University of California, San Diego
Ravi Salgia
Ravi Salgia City Of Hope National Medical Center
Theodore Karrison
Theodore Karrison University of Chicago
Mark J. Ratain
Mark J. Ratain University of Chicago
Harvey M. Golomb
Harvey M. Golomb University of Chicago
Merrill S. Kies
Merrill S. Kies The University of Texas MD Anderson Cancer Center
David R. Gandara
David R. Gandara University of California, Davis
Hedy L. Kindler
Hedy L. Kindler University of Chicago
Mark K. Ferguson
Mark K. Ferguson University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to many related academic options. For those starting as registered nurses, adn to np programs online offer an efficient way to become a nurse practitioner, opening up advanced practice opportunities.

If you are interested in health outside of clinical care, a nutrition bachelor degree online can lead to roles in dietetics, wellness coaching, or health education. These paths are ideal for those passionate about preventive medicine and healthy living.

For those drawn to the administrative side of healthcare, consider pursuing cahme accredited online mha programs. This is a strong pathway to leadership in hospitals and health organizations.

Current nurses seeking career advancement may also find rn to bsn online no clinicals programs appealing, especially for working professionals needing flexible schedules.

Whether your interests are clinical, administrative, or focused on community health, there are diverse online degrees to fit your goals and busy lifestyle.

Best Scientists Citing Everett E. Vokes

Trending Scientists

Recently Published Articles